China Artificial Hip Knee Joints Market Report: Market Size & Forecast 2026

The China artificial hip and knee joints market constitutes a critical component of the broader Asia-Pacific orthopedic devices industry, addressing the healthcare needs of one of the world's most populous nations. The market encompasses primary and revision joint replacement products, including cemented and cementless prostheses, surgical instruments, and associated biomaterials. China's domestic production capabilities have expanded substantially, with the country serving simultaneously as a major manufacturer and a high-volume consumer of joint replacement devices.

• •Estimated market size of approximately $23.35 billion in 2025, with steady expansion supported by demographic and epidemiological factors
• •Comprehensive product portfolio spanning titanium and cobalt-chromium alloy implants, ultra-high-molecular-weight polyethylene (UHMWPE) bearing surfaces, and ceramic-on-ceramic systems
• •Healthcare system reforms under Healthy China 2030 have progressively expanded insurance coverage for joint replacement procedures, improving patient access

The primary growth catalyst stems from China's accelerating demographic transition, with projections indicating that over 300 million citizens will be aged 60 or older by 2025, substantially increasing the population vulnerable to degenerative joint diseases such as osteoarthritis and rheumatoid arthritis. The epidemiological burden of knee osteoarthritis alone in China is growing at approximately 5.34% annually, creating sustained demand for arthroplasty interventions. Additionally, China's medical device procurement reforms, including centralized volume-based procurement (VBP) programs, have reduced device prices while simultaneously expanding market access through institutional adoption.

• •Rising prevalence of obesity-related and age-related knee osteoarthritis driving surgical intervention rates upward across urban and rural healthcare facilities
• •Government healthcare policy reforms have expanded reimbursement coverage for joint replacement procedures, reducing out-of-pocket costs for patients
• •Advancements in surgical techniques, including minimally invasive arthroplasty and computer-assisted navigation systems, have broadened patient eligibility for joint replacement surgery

Within the China market, hip and knee joint segments maintain distinct dynamics, with knee replacements typically representing the larger volume segment due to higher osteoarthritis prevalence in the weight-bearing joint. The market demonstrates significant geographic variation, with tier-one cities including Beijing, Shanghai, and Guangzhou exhibiting advanced adoption of premium implants and robotic-assisted surgery, while tier-three and tier-four cities represent the fastest-growing adoption segments as healthcare infrastructure expands. The western and central regions of China are witnessing accelerated market penetration driven by government rural healthcare initiatives.

• •Hip joint replacements commanded significant market share in the early adoption phase, though knee replacements have emerged as the dominant segment due to obesity-related degenerative joint disease prevalence
• •Eastern coastal provinces maintain higher per-capita procedure volumes and greater penetration of premium international brand products
• •Central and western provinces represent emerging high-growth markets as regional hospital capacity expands and surgical expertise disseminates beyond major metropolitan centers

What are the recent trends and outlook?

The market is positioned for sustained expansion through 2030, with growth trajectories supported by persistent demographic headwinds and policy frameworks encouraging indigenous medical device development. Technological innovation in implant materials, including advanced crosslinked polyethylene surfaces, oxidized zirconium alloys, and additive-manufactured porous titanium structures, is reshaping product differentiation strategies. The integration of artificial intelligence in surgical planning, three-dimensional preoperative modeling, and robotic-assisted implant positioning represents an emerging frontier that will likely reconfigure competitive advantage in premium market segments over the coming five-year period.

• •3D-printed patient-specific implants and customized surgical guides are gaining clinical adoption, particularly in complex revision procedures and deformity correction cases
• •Export-oriented manufacturing expansion positions China as an increasingly prominent global supplier of orthopedic implants, with domestic producers targeting emerging markets in Southeast Asia, Africa, and Latin America
• •Convergence of digital health platforms, remote patient monitoring, and predictive analytics for post-operative care management represents a significant adjacent opportunity for integrated care solutions